Drug intelligence / Profile preview

Mansoura Univ. EGFR/HER-2 compound 23

Development stage
Preclinical
Lead developer
Mansoura University
01

Overview

Mansoura Univ. EGFR/HER-2 compound 23: sourced facts only. name: "Compounds 23 and 39 were identified as possible EGFR, HER-2, and DHFR inhibitors."; target: "Compounds 23 and 39 were identified as possible EGFR, HER-2, and DHFR inhibitors."; target: "Compounds 23 and 39 were identified as possible EGFR, HER-2, and DHFR inhibitors."; target: "Compounds 23 and 39 were identified as possible EGFR, HER-2, and DHFR inhibitors."; developer: "Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, 35516 Mansoura, Egypt."; stage: "Compounds 23 and 39 exhibited potent activity against the MCF-7 breast cancer cell line, with IC50 values of 1.81 and 4.95 μM, respectively, compared to DOX and SOR (IC50 values of 4.17 and 7.26 μM, respectively)."

02

Targets

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Mansoura Univ. EGFR/HER-2 compound 23.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mansoura Univ. EGFR/HER-2 compound 23.

Work on Mansoura Univ. EGFR/HER-2 compound 23? Claim this page to correct or add information. Claim this page

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call